Wellpharma
- Company typePrivate
- Founded2004
- HeadquartersIseo, Italy
- Headcount11–50
- GTM typeB2C
- OfferingHardware or Manufacturing
Wellpharma firmographics
Firmographics- Name
- Wellpharma
- Legal name
- Wellpharma s.r.l.
- Website
- https://wellpharma.it
- Company type
- Private
- Founded year
- 2004
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Ownership category
- akta.pro rank
Wellpharma industry classification
Industry- Product category
- Pharmaceuticals & Dermatological Products
- NAICS
- Pharmaceutical Preparation Manufacturing (325412), Medicinal and Botanical Manufacturing (325411)
- SIC
- Pharmaceutical Preparations (2834), Perfumes, Cosmetics & Other Toilet Preparations (2844)
- akta.pro primary industry
- Dermatology Specialty Pharmaceuticals (HLAIACAL)
- akta.pro secondary industries
- Dermatology & Aesthetics Pharmaceuticals (HLAIAAAK), Dermocosmetics & Medical-Grade Skincare (CRABAAAF)
Keywords
Where Wellpharma is headquartered
LocationHeadquarters
- HQ city
- Iseo
- HQ country
- Italy
- HQ region
- Europe
Offices1 record
Markets served
Wellpharma business model
Business model- GTM type
- B2C
- Offering type
- Hardware or Manufacturing
- Cost components
- Supply Chain, Personnel, Operations, Marketing or Sales, Technology or R&D
Revenue model
- Pharmaceutical and Health Product Sales: Wellpharma generates revenue through the sale of pharmaceutical products, cosmetics, and dietary supplements. The company manufactures and distributes its own product line including Bioprostat, Wellskin creams, Psoradin, Veractiv, and Dermamix, as well as products under sales concession arrangements such as Flaminase. Products are sold primarily through pharmacy channels in Italy.
Go-to-market motion1 record
Distribution channels2 records
Marketing channels4 records
Wellpharma product offering
Product offeringCore offering
Wellpharma is an Italian pharmaceutical company that manufactures and distributes dermatological cosmetics (Wellskin cream line), dietary supplements (Psoradin, Psoradin Microbiota, Bioprostat), medical devices (Veractiv), and emollient sprays (Dermamix), focused on dermatology, urology, and general wellness. Products are sold exclusively through Italian pharmacies via national distributor BM FARMACEUTICI, with physician and pharmacist engagement supporting patient recommendations. The portfolio combines proprietary formulations with products distributed under sales concession arrangements.
Product overview
Wellpharma is a pharmaceutical company founded in 2004 specializing in dermatology, urology, otorhinolaryngology, pneumology, orthopedics, gynecology, dentistry, and general practice products. The product portfolio includes: dietary supplements (Psoradin Microbiota, Bioprostat, Psoradin), topical cosmetics (Wellskin Crema 5, Wellskin Crema 15, Dermamix), medical devices (Veractiv), and distributed products (Flaminase). Therapeutic areas focus on dermatological conditions (psoriasis, dry skin) and urological/supplementary health. Clinical studies support Psoradin and Bioprostat products.
Differentiator
Problem solved
Functional benefit
Brands
- Wellskin: Dermatological skincare line including Wellskin Crema 5 (5% urea for hydration) and Wellskin Crema 15 (15% urea for keratolytic action), containing borage oil and vitamin E for dry, scaly skin.
- Psoradin
- Bioprostat
- Veractiv
- Flaminase
- Dermamix
Products and services
- Psoradin Microbiota Eubiotic dietary supplement containing Lactobacillus Reuteri, Lactobacillus Rhamnosus, Lactobacillus Plantarum, Vitamin B12, and folic acid. Designed to favor intestinal microbiome balance (bacterial flora) for psoriasis patients with altered microbiota at both skin and intestinal levels by addressing the gut-skin axis. Intended for adult patients with psoriasis and as adjunct therapy.
- Bioprostat Food supplement containing Vitamin D3 and isoflavones from red clover extract, packaged as a pack of 60 capsules. Contributes to normal immune system function and supports cleansing functions of the organism. Marketed for urological and prostate health support.
- Wellskin Crema 5 Hydro-lipid oil-in-water emulsion (dermatological cream) containing 5% urea, borage oil rich in gamma-linolenic acid, and Vitamin E. Indicated for dry, scaly, and reddened skin, suitable for children. Free from parabens and lanolin. Provides hydrating action for mild skin dryness.
- Wellskin Crema 15 Hydro-lipid oil-in-water emulsion (dermatological cream) containing 15% urea, borage oil, and Vitamin E, packed in 60g tubes. Features keratolytic properties for treating dry, scaly, and reddened skin. Free from parabens and lanolin. Indicated for more severe dryness and scaling conditions than Wellskin Crema 5.
- Psoradin Omega 3 dietary supplement with vitamins and minerals, packaged in 45 soft capsules. Contains linseed oil, concentrated fish oil, zinc, chromium, selenium, and Vitamins A, D3, and E. Used as adjunct therapy for psoriasis patients.
- Veractiv Classified medical device in the form of a cutaneous solution designed to facilitate the removal of warts. Sold through pharmacy channel in Italy.
- Dermamix Spray emollient for dry skin treatment, packaged in 150ml spray bottles. Indicated for pathological conditions (atopic dermatitis, eczema, ichthyosis) and physiological dry skin. Can be used as emollient/moisturizer after shower or for elderly patients.
- Flaminase Product distributed under national sales concession (concessione nazionale di vendita). Available only in pharmacy channel ('Only in chemist shop').
Quantifiable outcome
- Psoradin Microbiota addresses psoriasis symptoms by targeting altered gut and skin microbiota
- +2 more outcomes
Companies that use Wellpharma
Customer profileSegments3 records
Ideal customer profiles2 records
Wellpharma technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature2 records
Wellpharma partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- BM FARMACEUTICIcoreBM FARMACEUTICI serves as the national distributor of Wellpharma products in Italy. The partnership is referenced on the Wellpharma website under Links and confirmed across multiple pages in both Italian and English versions, indicating a dedicated and established distribution relationship for the Italian market.
Scale indicators3 records
Recent moves5 records
Expansion highlights4 records
Wellpharma competitors and assessment
Company assessmentBroad incumbents
- Galderma: Global dermatology-focused pharmaceutical and consumer skin-health company; broader and more international than Wellpharma, but relevant as the dominant incumbent in dermatology they compete against in skin conditions.
- Menarini: Large Italian pharma company with broad dermatology, gastroenterology and consumer health offerings sold via pharmacies; relevant as a broad incumbent in the same Italian distribution channels.
- Recordati: Major Italian pharmaceutical group with dermatology, urology and specialty care franchises sold through pharmacy and HCP channels; broader portfolio but overlapping therapeutic areas and Italian footprint.
Direct peers
- Istituto Ganassini: Italian dermocosmetics company with brands sold through pharmacies and parapharmacies (e.g., Rilastil, Dermoflan). Closely comparable to Wellpharma's Wellskin/Dermamix positioning in medical-grade skincare via Italian pharmacy channel.
- Giuliani SpA: Italian pharmaceutical company with a portfolio spanning dermatology, gastroenterology and specialty supplements, distributed primarily through Italian pharmacies — directly comparable therapeutic mix and GTM to Wellpharma.
- Savoma Medicinali: Italian pharmaceutical company focused on dermatology, gynecology and specialty supplements distributed via Italian pharmacies — comparable therapeutic mix and pharmacy-channel GTM.
- BIOGROUP (Biolevi & affiliates): Italian pharma group active in dietary supplements and dermatology products sold through pharmacies; comparable in product type (supplements/cosmetics) and Italian pharmacy-channel distribution.
- Difa Cooper (Cantabria Labs): Italian affiliate of Cantabria Labs distributing dermo-cosmetic and dermatology products via Italian pharmacies, with a similar HCP/detailing-led go-to-market model to Wellpharma.
- Pasquali S.r.l. Italian company selling dermatological and nutritional products through pharmacies, including probiotics and dermatology supplements — overlaps with Wellpharma's Psoradin Microbiota and Bioprostat categories.
Others
- Pierre Fabre Italia: Italian arm of Pierre Fabre Group, with dermo-cosmetics and dermatology products (e.g., Ducray, A-Derma) sold through Italian pharmacies — comparable category overlap with Wellpharma's dermatology portfolio.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat4 records
Key risks6 records
Key highlights6 records
Customer concentration
Wellpharma social profiles
Digital presenceWellpharma financial estimates
Financial estimateRevenue estimate
Valuation estimate
Wellpharma leadership team
Management profileNumber of profiles
Wellpharma funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Wellpharma M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Wellpharma
What does Wellpharma do?
Wellpharma is an Italian pharmaceutical company that manufactures and distributes dermatological cosmetics (Wellskin cream line), dietary supplements (Psoradin, Psoradin Microbiota, Bioprostat), medical devices (Veractiv), and emollient sprays (Dermamix), focused on dermatology, urology, and general wellness. Products are sold exclusively through Italian pharmacies via national distributor BM FARMACEUTICI, with physician and pharmacist engagement supporting patient recommendations. The portfolio combines proprietary formulations with products distributed under sales concession arrangements.
Is Wellpharma a public or private company?
Wellpharma is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Wellpharma founded?
Wellpharma was founded in 2004. It employs 11 to 50 people.
Where is Wellpharma based?
Wellpharma is headquartered in Iseo, Italy, in the Europe region.
How does Wellpharma make money?
One revenue line is on record: pharmaceutical and Health Product Sales.
Who are Wellpharma's main competitors?
Broad incumbents on record are Galderma, Menarini and Recordati. Direct peers are Istituto Ganassini, Giuliani SpA, Savoma Medicinali, BIOGROUP (Biolevi & affiliates), Difa Cooper (Cantabria Labs) and Pasquali S.r.l.. Pierre Fabre Italia is listed as an others.
Does Wellpharma have an API?
No public API is recorded for Wellpharma.
What industry is Wellpharma in?
Wellpharma's product category is Pharmaceuticals & Dermatological Products. Its primary akta.pro industry code is HLAIACAL, Dermatology Specialty Pharmaceuticals, with a secondary code of HLAIAAAK, Dermatology & Aesthetics Pharmaceuticals. Its NAICS code is 325412 and its SIC code is 2834.